Skip to main content
. 2015 Oct;21(10):10.18553/jmcp.2015.21.10.902. doi: 10.18553/jmcp.2015.21.10.902

TABLE 2.

Comorbidities, Health Care Resource Use, and Health Care Costs in the Observation Period

Characteristicsa High-Cost Patientsb (n = 1,859) Lower-Cost Patientsb (n = 7,432) P Valuec
N or Mean % or SD N or Mean % or SD
Comorbidities
 Charlson Comorbidity Index 1.60 2.29 0.42 1.05 < 0.001
 Components of Charlson Comorbidity Index
  Chronic pulmonary disease 447 24.0% 784 10.5% < 0.001
  Mild-to-moderate diabetes 200 10.8% 387 5.2% < 0.001
  Rheumatologic disease 154 8.3% 176 2.4% < 0.001
  Congestive heart failure 226 12.2% 161 2.2% < 0.001
  Any malignancy including leukemia and lymphoma 138 7.4% 180 2.4% < 0.001
  Cerebrovascular disease 214 11.5% 197 2.7% < 0.001
  Diabetes with chronic complications 120 6.5% 126 1.7% < 0.001
  Peripheral vascular disease 123 6.6% 105 1.4% < 0.001
  Mild liver disease 92 4.9% 95 1.3% < 0.001
  Renal disease 144 7.7% 70 0.9% < 0.001
  Peptic ulcer disease 65 3.5% 52 0.7% < 0.001
  Myocardial infarction 73 3.9% 43 0.6% < 0.001
  Hemiplegia or paraplegia 49 2.6% 40 0.5% < 0.001
  Metastatic solid tumor 44 2.4% 16 0.2% < 0.001
  HIV/AIDS 19 1.0% 25 0.3% < 0.001
  Moderate or severe liver disease 32 1.7% 16 0.2% < 0.001
  Dementia 13 0.7% 14 0.2% < 0.001
 Other selected comorbidities
  Nonopioid substance abuse diagnoses 984 53.0% 3,351 47.2% < 0.001
  Psychotic disorders 1,244 67.1% 3,374 47.5% < 0.001
  Other mental disorders 1,302 70.2% 4,081 57.5% < 0.001
Annual Health Care Resource Use
 Medical resource use
  Any visit
   Inpatient 1,529 82.2% 2,702 36.4% < 0.001
   Emergency department 1,640 88.2% 4,528 60.9% < 0.001
   Outpatient 1,855 99.8% 7,274 97.9% < 0.001
   Drug/alcohol rehabilitation facility 559 30.1% 1,632 22.0% < 0.001
   Other 1,487 80.0% 4,005 53.9% < 0.001
  Number of visits/days
   Inpatient days 16.1 23.9 2.9 7.2 < 0.001
   Emergency department days 8.9 13.6 1.9 3.2 < 0.001
   Outpatient visits 38.2 24.6 18.7 15.9 < 0.001
   Drug/alcohol rehabilitation facility days 9.5 22.3 5.6 18.0 < 0.001
   Other visits 8.2 13.7 2.6 5.3 < 0.001
  Abuse-related medical resource use
   Inpatient days 4.7 10.7 1.6 4.7 < 0.001
   Emergency department days 1.3 3.0 0.5 1.1 < 0.001
   Outpatient visits 2.5 7.5 3.4 7.0 < 0.001
   Drug/alcohol rehabilitation facility days 4.6 14.9 4.3 16.4 < 0.001
   Other visits 0.6 2.6 0.7 2.6 < 0.001
Abuse-related share of total medical resource use
   Inpatient days 29% - 56% - -
   Emergency department days 15% - 25% - -
   Outpatient visits 7% - 18% - -
   Drug/alcohol rehabilitation facility days 49% - 76% - -
   Other visits 8% - 27% - -
 Prescription drug use
   Any prescription drug fill 1,802 96.9% 6,871 92.5% < 0.001
   Number of prescriptions filled 71.4 50 32.6 32 < 0.001
   Number of unique NDC numbers filled 29.0 20 12.9 11 < 0.001
Annual Health Care Costs $89,177 $87,211 $11,653 $9,031 < 0.001
 Medical costs $79,386 $86,986 $8,986 $8,075 < 0.001
   Inpatient $34,600 $68,531 $1,577 $3,752 < 0.001
   Emergency department $16,597 $35,913 $1,630 $3,102 < 0.001
   Outpatient $19,513 $25,233 $3,696 $4,474 < 0.001
   Drug/alcohol rehabilitation facility $4,393 $11,696 $1,263 $3,666 < 0.001
   Other $4,283 $10,949 $821 $2,178 < 0.001
 Abuse-related medical costs $15,706 $31,980 $3,429 $4,978 < 0.001
   Inpatient $8,089 $29,449 $909 $2,774 < 0.001
   Emergency department $3,320 $10,675 $559 $1,774 < 0.001
   Outpatient $1,231 $5,336 $617 $1,473 0.029
   Drug/alcohol rehabilitation facility $2,336 $7,924 $940 $3,106 < 0.001
   Other $730 $3,271 $405 $1,537 < 0.001
 Abuse-related share of total medical costs 20% - 38% - -
 Inpatient 23% - 58% - -
 Emergency department 20% - 34% - -
 Outpatient 6% - 17% - -
 Drug/alcohol rehabilitation facility 53% - 74% - -
 Other 17% - 49% - -
 Prescription drug costs $9,791 $16,811 $2,667 $3,864 < 0.001

aThe observation period was defined as the 12-month period centered on the index date.

bHigh-cost patients were defined as patients with health care costs in the top 20% of health care costs among all patients in the study cohort during the observation period.

cP values were calculated using chi-square tests for dichotomous variables and Wilcoxon rank-sum tests for continuous variables. Results were considered statistically significant at P < 0.05.

AIDS = acquired immune deficiency syndrome; HIV = human immunodeficiency virus; NDC = National Drug Code; SD = standard deviation.